(Q37401346)

20 August 2017

1 reference

title

Update on nuclear medicine imaging of neuroendocrine tumors (English)

1 reference

20 August 2017

Stanley J Goldsmith

1

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

75-84

1 reference

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

SPECT/CT hybrid imaging with 111In‐pentetreotide in assessment of neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

Intertumoural variability in functional imaging within patients suffering from neuroendocrine tumours. An observational, cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.75

21 January 2018

Identifiers

DOI

10.2217/14796694.5.1.75

1 reference

20 August 2017

1 reference